Fund Direct Advisors Inc

Item 5 – Fees and Compensation

*Please see Appendix C of your Advisory Agreement for your specific fee schedule.
Fees for services may be calculated as follows:

RETIREMENT PLAN ASSETS:

     Account Value $        Asset Based Fee Schedule
   Up to $1 million               0.40% - 0.30%
   $1 - $5 million                0.30% - 0.20%
   $5 - $10 million               0.20% - 0.15%
   $10 - $25 million              0.15% - 0.10%
   $25+ million                    0.10% - less

INDIVIDUAL WEALTH MANAGEMENT ASSETS:

     Account Value $        Asset Based Fee Schedule
   Up to $500,000                  1.50% max
   $500,000 - $1 million             1.20%
   $1 - $5 million                   1.00%
   $5 - $10 million                  0.85%
   $10+ million                      0.70%

All fees are subject to negotiation.

Fees are payable quarterly in arrears (Plan assets) and in advance (Individual assets) based
upon the value of the investment assets determined at month end for the prior period or by
the fixed fee arrangement option. The first payment is assessed and due at the end of the first
calendar quarter and will be assessed pro rata in the event the Investment Advisory
Agreement is executed at any time other than the first day of the current calendar quarter.
Subsequent payments are due and will be assessed on the first day of each new quarter. Our
firm directly debits management fees from the Client’s account or the Client may choose to
pay the fees directly to FDA. In some circumstances, including by client request, the
Retirement Plan fees may be charged as a flat/fixed fee.

Significant deposits and withdrawals during a calendar quarter may cause fees to be prorated,
at FDA’s discretion. Client fees will be refunded via a credit to the account for any errors or
miscalculations.

The method of charging the Client is specified in the Client’s Investment Advisory Agreement-
Appendix C, which is executed by the Client and FDA. FDA neither receives nor will take any
other forms of compensation for services rendered to Clients for these services. FDA will
cause the Client’s custodian to direct any and all 12b-1 fees, which may be a part of a Mutual
Fund’s Expense Ratio, back to the Client’s account. Clients may then use these fees as they
deem appropriate, i.e. to offset Plan expenses such as TPA (Third Party Administration) fees,
trustee/custodian fees, or to be left in a Client’s Plan Trust to be allocated to the Client’s Plan

Participants.

A Client agreement may be canceled at any time, by either party, for any reason upon receipt
of 30 (thirty) days written notice. Accounts initiated or terminated during a calendar quarter
will be charged a prorated fee. Upon termination of any account, any earned, unpaid fees will
be due and payable.

FDA’s fees are exclusive of brokerage commissions, transaction fees, and other related costs
and expenses which shall be incurred by the Client. Clients may incur certain charges imposed
by custodians, brokers, third party investment and other third parties such as fees charged by
managers, custodial fees, deferred sales charges, transfer taxes, wire transfer and electronic
fund fees, and other fees and taxes on brokerage accounts and securities transactions.

Advisory Agreements may be amended at any time by letter or other written instrument in a
manner mutually agreed upon by the Client and FDA.

All fees paid to FDA for investment management services are separate and distinct from the
fees and expenses charged by mutual funds to their shareholders. These fees and expenses are
described in each fund’s prospectus. These fees will generally include a management fee,
other fund expenses, and a possible distribution fee. If the fund also imposes sales charges, a
Client may pay an initial or deferred sales charge. A Client could invest in a mutual fund
directly, without our services. In that case, the Client would not receive the services provided
by our firm which are designed, among other things, to assist the Client in determining which
mutual fund or funds are most appropriate to each Client’s financial condition and objectives.
Accordingly, the Client should review both the fees charged by the mutual funds and FDA’s
fees to fully understand the total amount of fees to be paid by the Client and to thereby evaluate
the advisory services being provided.

FDA is deemed to be a fiduciary to advisory Clients that are employee benefit plans pursuant
to the Employee Retirement Income and Securities Act (“ERISA”), and regulations under the
Internal Revenue Code of 1986 (the “Code”), respectively. As such, our firm is subject to
specific duties and obligations under ERISA and the Internal Revenue Code including among
other things, restrictions concerning certain forms of compensation.

Item 7 – Types of Clients
FDA provides advisory services to the following types of Clients:
Individuals
Profit Sharing Plans
Government Pension Plans
For-Profit Pension Plans
Non-Profit Pension Plans
401(k) Plans
403(b) Plans
457 Plans

FDA does not have minimum account balance requirements for initiating or
maintaining an investment advisory relationship.